GOSSAMER BIO, INC. (GOSS) Operating cash flow 2017–2025
GOSSAMER BIO, INC. (GOSS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$171.3MFY2025 · since FY2017: -$5.7M → -$171.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171.3M | -4838.5% |
| FY2024 | -$3.5M | +97.8% |
| FY2023 | -$159.2M | +14.9% |
| FY2022 | -$187.0M | +1.0% |
| FY2021 | -$188.9M | -7.1% |
| FY2020 | -$176.4M | -21.8% |
| FY2019 | -$144.8M | -183.7% |
| FY2018 | -$51.0M | -788.5% |
| FY2017 | -$5.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice